Skip to content

Protea Biosciences Group, Inc.: 10-K filed 2014-03-31

What Protea Biosciences Group, Inc. reported in its annual report filed 2014-03-31 (fiscal FY 2013): 33 published measures, 108 facts as tagged in accession 0001144204-14-018911.

This filing

Form
10-K (annual report)
Filed
2014-03-31
Fiscal period
fiscal FY 2013
Accession
0001144204-14-018911 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Protea Biosciences Group, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-12-315,417,927USD
At 2012-12-314,212,031USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-12-31-3,011,025USD
At 2012-12-31-7,903,831USD
At 2011-12-31-4,503,782USD
At 2010-12-31-6,437,943USD
At 2009-12-31-2,197,353USD
At 2008-12-31-34,125USD
At 2007-12-31704,686USD
At 2006-12-31810,667USD
At 2005-12-31-787,867USD
At 2004-12-31-381,149USD
At 2003-12-31-201,856USD
At 2002-12-31-79,015USD
At 2001-12-31-37,524USD
At 2001-07-120USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-12-311,086,330USD
At 2012-12-3127,604USD
At 2011-12-31505,277USD
At 2001-07-120USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-11,417,670USD365
2001-07-13 to 2013-12-31-58,392,348USD4555
2012-01-01 to 2012-12-31-9,531,259USD366
2011-01-01 to 2011-12-31-11,497,332USD365
2010-01-01 to 2010-12-31-9,583,662USD365
2009-01-01 to 2009-12-31-5,329,737USD365
2008-01-01 to 2008-12-31-4,037,075USD366
2007-01-01 to 2007-12-31-2,854,072USD365
2006-01-01 to 2006-12-31-1,336,317USD365
2005-01-01 to 2005-12-31-1,034,429USD365
2004-01-01 to 2004-12-31-459,474USD366
2003-01-01 to 2003-12-31-420,431USD365
2002-01-01 to 2002-12-31-416,491USD365
2001-07-13 to 2001-12-31-474,399USD172

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-10,220,818USD365
2001-07-13 to 2013-12-31-47,816,287USD4555
2012-01-01 to 2012-12-31-8,521,997USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-12-3111,727,875USD365
2001-07-13 to 2013-12-3153,801,375USD4555
2012-01-01 to 2012-12-318,423,736USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-477,899USD365
2001-07-13 to 2013-12-31-4,921,923USD4555
2012-01-01 to 2012-12-31-358,190USD366

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2013-01-01 to 2013-12-3145,044,638shares365
2001-07-13 to 2013-12-3113,563,768shares4555
2012-01-01 to 2012-12-3128,953,072shares366

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-01-01 to 2013-12-310USD365
2001-07-13 to 2013-12-310USD4555
2012-01-01 to 2012-12-310USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-12-312,886,176USD
At 2012-12-312,790,464USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-12-31872,967USD365
2012-01-01 to 2012-12-31345,662USD366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-10,324,887USD365
2001-07-13 to 2013-12-31-55,301,792USD4555
2012-01-01 to 2012-12-31-8,980,340USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-12-312,508,502USD
At 2012-12-311,399,012USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-01-01 to 2013-12-31746,159USD365
2001-07-13 to 2013-12-312,776,613USD4555
2012-01-01 to 2012-12-31541,844USD366

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-12-316,225,105USD
At 2012-12-3110,032,836USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-12-31216,864USD
At 2012-12-31127,721USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-12-31465,334USD
At 2012-12-31905,186USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2013-01-01 to 2013-12-318,775,453USD365
2001-07-13 to 2013-12-3131,483,414USD4555
2012-01-01 to 2012-12-316,969,323USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-01-01 to 2013-12-312,772,926USD365
2001-07-13 to 2013-12-3128,534,725USD4555
2012-01-01 to 2012-12-312,845,267USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-12-3165,442,735shares
At 2012-12-3131,879,247shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-12-3154,517,358USD
At 2012-12-3137,993,350USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2013-12-3123,165USD
At 2012-12-31-6,403USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2013-12-312,634,313USD
At 2012-12-313,457,515USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-12-317,910,810USD
At 2012-12-317,031,215USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-12-315,024,634USD
At 2012-12-314,240,751USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-12-3123,249USD
At 2012-12-3122,555USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-11,417,670USD365
2001-07-13 to 2013-12-31-58,392,348USD4555
2012-01-01 to 2012-12-31-9,531,259USD366

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-11,388,102USD365
2001-07-13 to 2013-12-31-58,369,183USD4555
2012-01-01 to 2012-12-31-9,552,481USD366

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-01-01 to 2013-12-31844,888USD365
2001-07-13 to 2013-12-315,243,382USD4555
2012-01-01 to 2012-12-311,009,140USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-1,092,783USD365
2001-07-13 to 2013-12-31-3,090,556USD4555
2012-01-01 to 2012-12-31-550,919USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2013-01-01 to 2013-12-319,352,837USD365
2001-07-13 to 2013-12-3135,120,847USD4555
2012-01-01 to 2012-12-315,738,521USD366

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-3193,143USD365
2001-07-13 to 2013-12-31250,896USD4555
2012-01-01 to 2012-12-3181,103USD366

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-439,852USD365
2001-07-13 to 2013-12-31465,334USD4555
2012-01-01 to 2012-12-31681,850USD366

Inspect the source

Entity
Protea Biosciences Group, Inc. / CIK 0001335103
Captured
SEC response SHA-256
6b487b6d6aa0a735e07855358b10c0014003743452cad5b8c8bf2155ac6c1078

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001335103.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))